Skip to main content
. 2021 Aug 18;8:722032. doi: 10.3389/fnut.2021.722032

Table 4.

Quality assessment of included cross-sectional studies.

References Item 1 Item 2 Item 3 Item 4 Item 5 Item 6 Item 7 Item 8 Item 9 Item 10 Quality
Adeyemi
et al. (18)
Yes Yes Yes Yes No No No Yes Unclear No Moderate
Klassen
et al. (38)
Yes Yes Yes Yes No Yes No No Unclear Yes Moderate
Mikula
et al. (39)
Yes Yes No No No No No No Unclear Yes Moderate
Flauzino
et al. (40)
Yes No No Yes No Yes No Yes Unclear No Moderate
Paul
et al. (41)
Yes Yes No Unclear No No No Yes Unclear No Moderate
Ross
et al. (29)
Yes Yes Yes Unclear No Yes No Yes Unclear No Moderate
Thuppal
et al. (30)
Yes Yes Yes Unclear No Yes No Yes Unclear No Moderate
Ceballos
et al. (37)
Yes Yes Yes Unclear No No No Yes Unclear No Moderate
Hidron
et al. (32)
Yes No Yes Yes No No No Yes Unclear No Moderate

The 10 evaluation items are as follows:

Item 1 Define the source of information (survey, record review).

Item 2 List the inclusion and exclusion criteria for exposed and unexposed subjects (cases and controls) or refer to previous publications.

Item 3 Indicate the time period used for identifying patients.

Item 4 Indicate whether or not the subjects were consecutive, if not population-based.

Item 5 Indicate if the evaluators of the subjective components of the study were masked to other aspects of the status of the participants.

Item 6 Describe any assessments undertaken for quality assurance purposes (e.g., test/retest of primary outcome measurements).

Item 7 Explain the exclusion of any patient from the analysis.

Item 8 Describe how confounding variables were assessed and/or controlled.

Item 9 If applicable, explain how missing data were handled in the analysis.

Item 10 Summarize the patient response rates and completeness of the data collection.